Belize vs Congo: Amphetamine use disorder death rate
Belize
0.01 deaths per 100,000 people
in 2021
Congo
0.01 deaths per 100,000 people
in 2021
Belize rank
106th
Congo rank
106th
Amphetamine use disorder death rate over time
- Belize
- Congo
How they compare
Belize currently reports 0.01 deaths per 100,000 people against 0.01 deaths per 100,000 people in Congo, a difference of 0 deaths per 100,000 people.
The two have swapped places 2 times across 22 shared years of data; in 2000 it was Congo ahead.
Belize ranks 106th and Congo ranks 106th of 194 countries.
Belize has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Belize | Congo | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.01 deaths per 100,000 people | 0.01 deaths per 100,000 people | 0 deaths per 100,000 people | — |
| 2010s | 0.011 deaths per 100,000 people | 0.01 deaths per 100,000 people | 0.001 deaths per 100,000 people | Belize |
| 2020s | 0.01 deaths per 100,000 people | 0.01 deaths per 100,000 people | 0 deaths per 100,000 people | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher amphetamine use disorder death rate, Belize or Congo?
- Belize, at 0.01 deaths per 100,000 people against 0.01 deaths per 100,000 people in Congo as of 2021.
- What is the difference in amphetamine use disorder death rate between Belize and Congo?
- 0 deaths per 100,000 people, with Belize ahead.
- How many years of comparable data are there for Belize and Congo?
- 22 years are reported by both, from 2000 to 2021.
- How do Belize and Congo rank globally for amphetamine use disorder death rate?
- Belize ranks 106th and Congo ranks 106th of 194 countries.
- Where does this data come from?
- World Health Organization (2024) – with major processing by Our World in Data, published as Amphetamine use disorder death rate. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of deaths from amphetamine use disorders in both sexes, per 100,000 people.